Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on June 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Market Small Molecule Drug (Test Article) Supply

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424690
New
SLED
Chemical Products Qualified Vendor List - Additional Vendors
Solicitation # STATE 0000000547SL
The State of Missouri Office of Administration, Division of Purchasing, is soliciting additional qualified vendors to be added to a Qualified Vendor List (QVL) for the supply of chemical products. These materials support the Missouri Department of Corrections, Missouri Vocational Enterprises, and the Chemical Factory at the Eastern Reception and Diagnostic Correctional Center. The contract period runs from the date of award through March 9, 2027, with the state holding an option to renew for two additional one-year periods. Because of market volatility, pricing is not requested during the initial solicitation; instead, the state will request firm, fixed-price quotes from QVL contractors on an as-needed basis. Awards for specific orders will be granted to the lowest and best vendor, with evaluation factors including price, Domestic Procurement Act preferences, and bonus points for Missouri service-disabled veteran business enterprises or certified nonprofit organizations and workshops. Supplies must be delivered Free On Board (FOB) Destination to the Chemical Factory in Bonne Terre, Missouri, typically within ten calendar days of a properly executed order. Contractors must comply with strict safety and hazard communication standards, including providing warning labels and Safety Data Sheets (SDS) with shipments. Compliance with the Domestic Products Procurement Act (Buy American) is required, and vendors must certify the point of manufacture for their products. Payments are issued within 30 calendar days of receiving a valid, itemized invoice. Proposals must be submitted electronically via the MissouriBUYS portal, including completed vendor response exhibits and a comprehensive list of chemical products to be considered responsive.
PROC OA DIVISION OF PURCHASING PROCUREMENTS

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Show more

The contract requires the procurement and supply of a specified marketed small molecule drug designated as the test article for research purposes, encompassing all associated logistics such as handling, storage under appropriate conditions, and strict maintenance of chain-of-custody documentation to ensure integrity and traceability. Comprehensive batch documentation must be provided, adhering to regulatory and quality standards appropriate for research use, with no requirement for commercial distribution or clinical application. The work is structured as a subcontract under the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, with the NAICS code 424690 indicating pharmaceutical and cosmetic product merchant wholesalers. The solicitation was posted on June 22, 2026, with responses due by July 6, 2026, at 5:00 PM, and performance is expected to occur without a specified physical location, suggesting flexibility in execution as long as compliance with documentation and handling standards is met.

General Info

Procure and supply small molecule drug for research with strict chain-of-custody and batch documentation under FDA subcontract.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

424690 - Other Chemical and Allied Products Merchant WholesalersView NAICS

Place of Performance

MD, USA

Set-Aside

NONE

Documents

This scope was carved out of 75F40126Q134171.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

CNS Organoid Neuropharmacological Analysis

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Procure and supply the specified marketed small molecule drug (test article), including handling, storage, chain-of-custody, and batch documentation for research use.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS